13 May 2022 18:36
PT Kimia Farma Tbk (KAEF), a pharmaceutical company under PT Bio Farma (Persero), announced the plan of distributing cash dividends of IDR 90.68 billion or IDR 16.33 per share following the result of the General Shareholders Meeting.
Kimia Farma to share cash dividends of IDR 90.68 billion
12 May 2022 05:43
PT Kimia Farma Tbk will direct its attention to reduce the dependency on imported raw materials for medicine by 13.86% in 2022 by optimising the utilisation of production plants and commercialisation of its self-manufactured raw materials.
Kimia Farma focuses to lower dependency on imported materials by 13.86%
12 May 2022 05:22
The state-owned pharmaceutical company, PT Kimia Farma Tbk (KAEF), seeks revenue growth of 11% in 2022 after reflecting on its success of attaining sales growth of 28.49% in 2021 to IDR 12.85 trillion.
Kimia Farma aims for 11% revenue growth in 202212 May 2022 05:16
PT Kimia Farma Tbk (KAEF) gears up to welcome new strategic investors through a rights issue that is scheduled to be completed in July 2022.
KAEF to launch a rights issue, eyeing strategic investors24 Sep 2021 12:43
PT Kimia Farma (Persero) Tbk (KAEF) scores IDR 53.39 billion in the current year net profit of H1 2021, increasing from the profit reported in the same period in 2020 of IDR 51 billion.
Kimia Farma collects profit of IDR 53.39 billion19 Aug 2021 06:38
The Extraordinary General Shareholders Meeting of PT Kimia Farma Tbk (KAEF) approved the plan of raising its capital by offering new shares with preemptive rights.
Shareholders meeting agrees on KAEF’s rights issue plan13 Jul 2021 09:01
PT Kimia Farma Tbk (KAEF) would launch a rights issue by offering mandatory convertible bonds.
Kimia Farma to perform a rights issue with convertible bonds24 May 2021 12:56
Erick Thohir, the Minister of State-Owned Enterprise (BUMN), assigns Laksono Trisnantoro as the President Commissary of PT Indofarma (Persero) Tbk (INAF), replacing Mayjen (Purn) Daniel Tjen.
Erick Thohir to replace Agus Terawan’s allies in BUMN30 Apr 2021 11:46
The employees of PT Kimia Farma (Persero) Tbk (KAEF), who reused antigen test kits to the customers in Kualanamu Airport, Medan, North Sumatera, were estimated to obtain an IDR 1.8 billion profit.
The Kimia Farma case suspects swindled IDR 1.8 bilion from reusing antigen test kits
30 Apr 2021 05:00
PT Kimia Farma Tbk (KAEF), a state-owned pharmaceutical company, to share the dividend of IDR 7.06 billion or 40% of its net profit in 2020.
Kimia Farma to distribute 40% of its net profit in 2020 as dividend